日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/11/09 | 7,210 | 7,390 | 7,190 | 7,330 | +150 | +2.1% | 422,200 |
| 2018/11/08 | 6,840 | 7,220 | 6,840 | 7,180 | +590 | +9% | 458,000 |
| 2018/11/07 | 6,650 | 6,780 | 6,510 | 6,590 | -50 | -0.8% | 377,000 |
| 2018/11/06 | 6,500 | 6,690 | 6,500 | 6,640 | +150 | +2.3% | 163,000 |
| 2018/11/05 | 6,550 | 6,590 | 6,460 | 6,490 | -80 | -1.2% | 176,900 |
| 2018/11/02 | 6,470 | 6,590 | 6,410 | 6,570 | +120 | +1.9% | 345,900 |
| 2018/11/01 | 6,500 | 6,620 | 6,420 | 6,450 | -60 | -0.9% | 218,500 |
| 2018/10/31 | 6,450 | 6,540 | 6,310 | 6,510 | +30 | +0.5% | 214,400 |
| 2018/10/30 | 6,360 | 6,520 | 6,360 | 6,480 | +110 | +1.7% | 180,800 |
| 2018/10/29 | 6,430 | 6,550 | 6,360 | 6,370 | -20 | -0.3% | 120,600 |
| 2018/10/26 | 6,580 | 6,590 | 6,310 | 6,390 | -140 | -2.1% | 210,600 |
| 2018/10/25 | 6,560 | 6,620 | 6,510 | 6,530 | -190 | -2.8% | 205,800 |
| 2018/10/24 | 6,630 | 6,740 | 6,610 | 6,720 | +160 | +2.4% | 270,100 |
| 2018/10/23 | 6,850 | 6,850 | 6,550 | 6,560 | -390 | -5.6% | 284,000 |
| 2018/10/22 | 6,840 | 6,990 | 6,810 | 6,950 | +60 | +0.9% | 163,400 |
| 2018/10/19 | 6,820 | 6,980 | 6,790 | 6,890 | -150 | -2.1% | 249,200 |
| 2018/10/18 | 7,050 | 7,160 | 7,010 | 7,040 | +80 | +1.1% | 239,300 |
| 2018/10/17 | 6,850 | 6,960 | 6,650 | 6,960 | +210 | +3.1% | 298,100 |
| 2018/10/16 | 6,710 | 6,830 | 6,690 | 6,750 | -40 | -0.6% | 256,600 |
| 2018/10/15 | 6,850 | 6,880 | 6,760 | 6,790 | -120 | -1.7% | 254,900 |
| 2018/10/12 | 7,060 | 7,160 | 6,890 | 6,910 | -240 | -3.4% | 266,400 |
| 2018/10/11 | 7,070 | 7,190 | 7,000 | 7,150 | -70 | -1% | 412,000 |
| 2018/10/10 | 7,140 | 7,320 | 7,090 | 7,220 | +180 | +2.6% | 302,500 |
| 2018/10/09 | 7,180 | 7,320 | 6,940 | 7,040 | -290 | -4% | 460,500 |
| 2018/10/05 | 7,430 | 7,600 | 7,230 | 7,330 | -180 | -2.4% | 360,400 |
| 2018/10/04 | 7,560 | 7,610 | 7,400 | 7,510 | ±0 | ±0% | 563,700 |
| 2018/10/03 | 7,410 | 7,580 | 7,410 | 7,510 | +110 | +1.5% | 316,200 |
| 2018/10/02 | 7,440 | 7,480 | 7,320 | 7,400 | +40 | +0.5% | 164,000 |
| 2018/10/01 | 7,450 | 7,470 | 7,270 | 7,360 | -90 | -1.2% | 283,500 |
| 2018/09/28 | 7,430 | 7,520 | 7,370 | 7,450 | +100 | +1.4% | 420,000 |
| 2018/09/27 | 7,400 | 7,490 | 7,300 | 7,350 | -30 | -0.4% | 461,500 |
| 2018/09/26 | 7,220 | 7,380 | 7,160 | 7,380 | +190 | +2.6% | 470,400 |
| 2018/09/25 | 6,980 | 7,230 | 6,960 | 7,190 | +290 | +4.2% | 356,800 |
| 2018/09/21 | 6,770 | 6,960 | 6,710 | 6,900 | +140 | +2.1% | 262,700 |
| 2018/09/20 | 6,930 | 6,940 | 6,710 | 6,760 | -170 | -2.5% | 230,300 |
| 2018/09/19 | 6,970 | 6,990 | 6,900 | 6,930 | +50 | +0.7% | 181,800 |
| 2018/09/18 | 6,800 | 6,900 | 6,720 | 6,880 | +60 | +0.9% | 153,300 |
| 2018/09/14 | 6,990 | 6,990 | 6,780 | 6,820 | -100 | -1.4% | 183,300 |
| 2018/09/13 | 6,810 | 6,970 | 6,790 | 6,920 | +150 | +2.2% | 215,200 |
| 2018/09/12 | 6,880 | 6,910 | 6,660 | 6,770 | -10 | -0.1% | 245,800 |
| 2018/09/11 | 6,720 | 6,840 | 6,700 | 6,780 | +80 | +1.2% | 190,300 |
| 2018/09/10 | 6,630 | 6,790 | 6,630 | 6,700 | +70 | +1.1% | 144,200 |
| 2018/09/07 | 6,700 | 6,770 | 6,540 | 6,630 | -110 | -1.6% | 280,500 |
| 2018/09/06 | 6,720 | 6,830 | 6,680 | 6,740 | -20 | -0.3% | 190,200 |
| 2018/09/05 | 6,710 | 6,790 | 6,610 | 6,760 | +10 | +0.1% | 228,600 |
| 2018/09/04 | 6,640 | 6,780 | 6,610 | 6,750 | +240 | +3.7% | 247,200 |
| 2018/09/03 | 6,490 | 6,530 | 6,410 | 6,510 | -20 | -0.3% | 106,700 |
| 2018/08/31 | 6,470 | 6,570 | 6,440 | 6,530 | +60 | +0.9% | 138,800 |
| 2018/08/30 | 6,590 | 6,590 | 6,400 | 6,470 | -20 | -0.3% | 164,500 |
| 2018/08/29 | 6,460 | 6,520 | 6,440 | 6,490 | +90 | +1.4% | 166,400 |
1601～
1650
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
